-
Mar 17, 2026IPF Drug Development Challenges And Solutions | NHP Models With CT Imaging & PFTExplore how advanced NHP pulmonary fibrosis models, quantitative CT imaging, and pulmonary function testing improve translational success in IPF drug development. -
Mar 11, 2026AI Markerless NHP 3D Behavior Analysis System For Preclinical ResearchLearn how the AI-based NBAS markerless 3D behavior analysis system enables accurate non-human primate behavioral tracking for neuroscience and drug development studies. -
Mar 10, 2026Evaluating DMPK Properties Of Candidate Compounds in Early Drug Discovery | P...Learn how key pharmacokinetic parameters—including clearance, volume of distribution, half-life, oral bioavailability, and exposure—are used to evaluate DMPK properties of candi... -
Feb 25, 2026MRI-Guided CNS Delivery in NHP Models | Translational IMRI & CED PlatformPrisys Biotech offers MRI-guided precision CNS delivery in NHP models, integrating intraprocedural MRI and convection-enhanced delivery (CED) to support translational gene thera... -
Feb 14, 2026NHP CNS Biodistribution Studies | Intrathecal RNA Delivery | PRISYS BiotechOptimize your RNA therapeutic pipeline with NHP CNS biodistribution studies. Featuring precision intrathecal delivery, imaging-guided administration, and regional brain analysis... -
Feb 13, 2026Translational PK/PD Framework: Cynomolgus Monkey To Human Dose Prediction | P...Explore a structured translational PK/PD framework integrating in vitro pharmacology and NHP models to refine human dose prediction and clinical proof-of-concept. -
Jan 27, 2026When Pain Becomes A Memory: Emotional Drivers Of Chronic Pain & The NHP Model...Why do analgesics fail in the clinic? Discover how chronic pain acts as a learned emotional memory and how Prisys Biotech's Non-Human Primate (NHP) models bridge the translation... -
Jan 23, 2026Multi-Endpoint Pain Assessment: The Future Of Analgesic Drug DevelopmentDiscover why single-endpoint pain models are slowing analgesic R&D. Learn how a multi-dimensional approach in NHP models offers a more complete, clinically relevant picture of p... -
Jan 20, 2026Why Do So Many Analgesics Fail in Preclinical Trials? The Answer Lies in How ...Discover why promising analgesic drugs often fail in clinical trials. Learn how shifting from simple reflex tests to multidimensional NHP pain models is key to successful transl... -
Jan 13, 2026Blood Sampling Time Point Design in Pharmacokinetic (PK) Studies | Prisys Bio...Learn how to design robust blood sampling time points for pharmacokinetic studies. This guide explains regulatory principles, phase-specific sampling strategies, and practical P... -
Jan 09, 2026PK Statistics: Non-compartmental Analysis (NCA) Parameters And Preclinical Ap...A comprehensive guide to Non-compartmental Analysis (NCA) in pharmacokinetics. Learn about key PK parameters (AUC, Cmax, CL, Vz) and their significance in preclinical NHP studie... -
Jan 06, 2026Why Non-Human Primate Models Are Critical For CNS Oligonucleotide TherapeuticsExplore why non-human primate models are essential for translating CNS oligonucleotide therapeutics, from biodistribution heterogeneity to precision brain delivery and clinical ...
